{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:36:38Z","timestamp":1792640198308,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T00:00:00Z","timestamp":1278979200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10549-010-1017-6","type":"journal-article","created":{"date-parts":[[2010,7,12]],"date-time":"2010-07-12T07:44:49Z","timestamp":1278920689000},"page":"611-622","source":"Crossref","is-referenced-by-count":24,"title":["Ionizing radiation or mitomycin-induced micronuclei in lymphocytes of BRCA1 or BRCA2 mutation carriers"],"prefix":"10.1007","volume":"127","author":[{"given":"Sara","family":"Guti\u00e9rrez-Enr\u00edquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ram\u00f3n y Cajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Cornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Ribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Baiget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orland","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,7,13]]},"reference":[{"key":"1017_CR1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrc2054","volume":"7","author":"JD Fackenthal","year":"2007","unstructured":"Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937\u2013948","journal-title":"Nat Rev Cancer"},{"key":"1017_CR2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1042\/BST0340633","volume":"34","author":"SJ Boulton","year":"2006","unstructured":"Boulton SJ (2006) Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34:633\u2013645","journal-title":"Biochem Soc Trans"},{"key":"1017_CR3","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1038\/sj.onc.1209874","volume":"25","author":"K Gudmundsdottir","year":"2006","unstructured":"Gudmundsdottir K, Ashworth A (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25:5864\u20135874","journal-title":"Oncogene"},{"key":"1017_CR4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4161\/cc.6.8.4105","volume":"6","author":"I Cousineau","year":"2007","unstructured":"Cousineau I, Belmaaza A (2007) BRCA1 haploinsufficiency, but not heterozygosity for a BRCA1-truncating mutation, deregulates homologous recombination. Cell Cycle 6:962\u2013971","journal-title":"Cell Cycle"},{"key":"1017_CR5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.pathol.3.121806.151422","volume":"4","author":"AR Venkitaraman","year":"2009","unstructured":"Venkitaraman AR (2009) Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu Rev Pathol 4:461\u2013487","journal-title":"Annu Rev Pathol"},{"key":"1017_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2005.11.041","volume":"243","author":"K Arnold","year":"2006","unstructured":"Arnold K, Kim MK, Frerk K, Edler L, Savelyeva L, Schmezer P, Wiedemeyer R (2006) Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair. Cancer Lett 243:90\u2013100","journal-title":"Cancer Lett"},{"key":"1017_CR7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000077511","volume":"104","author":"G Speit","year":"2004","unstructured":"Speit G, Trenz K (2004) Chromosomal mutagen sensitivity associated with mutations in BRCA genes. Cytogenet Genome Res 104:325\u2013332","journal-title":"Cytogenet Genome Res"},{"key":"1017_CR8","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nprot.2007.77","volume":"2","author":"M Fenech","year":"2007","unstructured":"Fenech M (2007) Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084\u20131104","journal-title":"Nat Protoc"},{"key":"1017_CR9","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/mutage\/18.2.187","volume":"18","author":"P Thomas","year":"2003","unstructured":"Thomas P, Umegaki K, Fenech M (2003) Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis 18:187\u2013194","journal-title":"Mutagenesis"},{"key":"1017_CR10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/0955300021000016558","volume":"78","author":"LJ Fell","year":"2002","unstructured":"Fell LJ, Paul ND, McMillan TJ (2002) Role for non-homologous end-joining in the repair of UVA-induced DNA damage. Int J Radiat Biol 78:1023\u20131027","journal-title":"Int J Radiat Biol"},{"key":"1017_CR11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mrfmmm.2005.12.016","volume":"596","author":"Y Ouyang","year":"2006","unstructured":"Ouyang Y, Kwon YT, An JY, Eller D, Tsai SC, Diaz-Perez S, Troke JJ, Teitell MA, Marahrens Y (2006) Loss of Ubr2, an E3 ubiquitin ligase, leads to chromosome fragility and impaired homologous recombinational repair. Mutat Res 596:64\u201375","journal-title":"Mutat Res"},{"key":"1017_CR12","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1158\/0008-5472.CAN-09-2177","volume":"69","author":"J Yue","year":"2009","unstructured":"Yue J, Wang Q, Lu H, Brenneman M, Fan F, Shen Z (2009) The cytoskeleton protein filamin-A is required for an efficient recombinational DNA double strand break repair. Cancer Res 69:7978\u20137985","journal-title":"Cancer Res"},{"key":"1017_CR13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/HP.0b013e3181b85044","volume":"98","author":"M Fenech","year":"2010","unstructured":"Fenech M (2010) The lymphocyte cytokinesis-block micronucleus cytome assay and its application in radiation biodosimetry. Health Phys 98:234\u2013243","journal-title":"Health Phys"},{"key":"1017_CR14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1667\/0033-7587(2002)157[0678:POMILO]2.0.CO;2","volume":"157","author":"TK Lee","year":"2002","unstructured":"Lee TK, Allison RR, O\u2019Brien KF, Naves JL, Karlsson UL, Wiley AL (2002) Persistence of micronuclei in lymphocytes of cancer patients after radiotherapy. Radiat Res 157:678\u2013684","journal-title":"Radiat Res"},{"key":"1017_CR15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1054\/bjoc.2000.1701","volume":"84","author":"K Baria","year":"2001","unstructured":"Baria K, Warren C, Roberts SA, West CM, Scott D (2001) Chromosomal radiosensitivity as a marker of predisposition to common cancers? Br J Cancer 84:892\u2013896","journal-title":"Br J Cancer"},{"key":"1017_CR16","doi-asserted-by":"crossref","first-page":"6449","DOI":"10.1158\/0008-5472.CAN-06-0326","volume":"66","author":"RA El-Zein","year":"2006","unstructured":"El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR (2006) Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66:6449\u20136456","journal-title":"Cancer Res"},{"key":"1017_CR17","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1158\/1055-9965.EPI-07-2827","volume":"17","author":"RA El-Zein","year":"2008","unstructured":"El-Zein RA, Fenech M, Lopez MS, Spitz MR, Etzel CJ (2008) Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev 17:1111\u20131119","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1017_CR18","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/sj.bjc.6600628","volume":"87","author":"A Baeyens","year":"2002","unstructured":"Baeyens A, Thierens H, Claes K, Poppe B, Messiaen L, de RL, Vral A (2002) Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer 87:1379\u20131385","journal-title":"Br J Cancer"},{"key":"1017_CR19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/09553000050201109","volume":"76","author":"W Burrill","year":"2000","unstructured":"Burrill W, Barber JB, Roberts SA, Bulman B, Scott D (2000) Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay. Int J Radiat Biol 76:1617\u20131619","journal-title":"Int J Radiat Biol"},{"key":"1017_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1996.307","volume":"74","author":"R Parshad","year":"1996","unstructured":"Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford KK (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74:1\u20135","journal-title":"Br J Cancer"},{"key":"1017_CR21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1086\/302544","volume":"65","author":"SA Roberts","year":"1999","unstructured":"Roberts SA, Spreadborough AR, Bulman B, Barber JB, Evans DG, Scott D (1999) Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet 65:784\u2013794","journal-title":"Am J Hum Genet"},{"key":"1017_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/095530099140744","volume":"75","author":"D Scott","year":"1999","unstructured":"Scott D, Barber JB, Spreadborough AR, Burrill W, Roberts SA (1999) Increased chromosomal radiosensitivity in breast cancer patients: a comparison of two assays. Int J Radiat Biol 75:1\u201310","journal-title":"Int J Radiat Biol"},{"key":"1017_CR23","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1158\/0008-5472.CAN-06-1007","volume":"66","author":"X Wu","year":"2006","unstructured":"Wu X, Spitz MR, Amos CI et al (2006) Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res 66:5993\u20135996","journal-title":"Cancer Res"},{"key":"1017_CR24","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/09553000400017937","volume":"80","author":"A Baeyens","year":"2004","unstructured":"Baeyens A, Thierens H, Claes K, Poppe B, de RL, Vral A (2004) Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol 80:745\u2013756","journal-title":"Int J Radiat Biol"},{"key":"1017_CR25","first-page":"5948","volume":"61","author":"K Baria","year":"2001","unstructured":"Baria K, Warren C, Roberts SA, West CM, Evans DG, Varley JM, Scott D (2001) Correspondence re: A. Rothfuss et al., Induced micronucleus frequencies in peripheral blood lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res., 60: 390\u2013394, 2000. Cancer Res 61:5948\u20135949","journal-title":"Cancer Res"},{"key":"1017_CR26","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/ijc.22915","volume":"121","author":"J Barwell","year":"2007","unstructured":"Barwell J, Pangon L, Georgiou A et al (2007) Lymphocyte radiosensitivity in BRCA1 and BRCA2 mutation carriers and implications for breast cancer susceptibility. Int J Cancer 121:1631\u20131636","journal-title":"Int J Cancer"},{"key":"1017_CR27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/ijc.10109","volume":"97","author":"TA Buchholz","year":"2002","unstructured":"Buchholz TA, Wu X, Hussain A et al (2002) Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int J Cancer 97:557\u2013561","journal-title":"Int J Cancer"},{"key":"1017_CR28","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.dnarep.2008.08.001","volume":"7","author":"E Febrer","year":"2008","unstructured":"Febrer E, Mestres M, Caballin MR, Barrios L, Ribas M, Gutierrez-Enriquez S, Alonso C, Cajal T, Francesc BJ (2008) Mitotic delay in lymphocytes from BRCA1 heterozygotes unable to reduce the radiation-induced chromosomal damage. DNA Repair (Amst) 7:1907\u20131911","journal-title":"DNA Repair (Amst)"},{"key":"1017_CR29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.bjc.6602912","volume":"94","author":"Z Kote-Jarai","year":"2006","unstructured":"Kote-Jarai Z, Salmon A, Mengitsu T et al (2006) Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers. Br J Cancer 94:308\u2013310","journal-title":"Br J Cancer"},{"key":"1017_CR30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.bjc.6603528","volume":"96","author":"J Kotsopoulos","year":"2007","unstructured":"Kotsopoulos J, Chen Z, Vallis KA, Poll A, Ainsworth P, Narod SA (2007) DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers. Br J Cancer 96:118\u2013125","journal-title":"Br J Cancer"},{"key":"1017_CR31","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1055-9965.EPI-03-0448","volume":"14","author":"E Kowalska","year":"2005","unstructured":"Kowalska E, Narod SA, Huzarski T, Zajaczek S, Huzarska J, Gorski B, Lubinski J (2005) Increased rates of chromosome breakage in BRCA1 carriers are normalized by oral selenium supplementation. Cancer Epidemiol Biomarkers Prev 14:1302\u20131306","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1017_CR32","first-page":"390","volume":"60","author":"A Rothfuss","year":"2000","unstructured":"Rothfuss A, Schutz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speit G (2000) Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. Cancer Res 60:390\u2013394","journal-title":"Cancer Res"},{"key":"1017_CR33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0027-5107(01)00300-1","volume":"500","author":"K Trenz","year":"2002","unstructured":"Trenz K, Rothfuss A, Schutz P, Speit G (2002) Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutation. Mutat Res 500:89\u201396","journal-title":"Mutat Res"},{"key":"1017_CR34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.mrrev.2003.06.011","volume":"544","author":"K Trenz","year":"2003","unstructured":"Trenz K, Lugowski S, Jahrsdorfer U, Jainta S, Vogel W, Speit G (2003) Enhanced sensitivity of peripheral blood lymphocytes from women carrying a BRCA1 mutation towards the mutagenic effects of various cytostatics. Mutat Res 544:279\u2013288","journal-title":"Mutat Res"},{"key":"1017_CR35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/mutage\/gel035","volume":"21","author":"D Varga","year":"2006","unstructured":"Varga D, Hoegel J, Maier C et al (2006) On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. Mutagenesis 21:313\u2013320","journal-title":"Mutagenesis"},{"key":"1017_CR36","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.bjc.6603977","volume":"97","author":"W Vogel","year":"2007","unstructured":"Vogel W, Surowy H (2007) Reduced DNA repair in BRCA1 mutation carriers undetectable before onset of breast cancer? Br J Cancer 97:1184\u20131186","journal-title":"Br J Cancer"},{"key":"1017_CR37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1098-2280(2001)37:1<31::AID-EM1004>3.0.CO;2-P","volume":"37","author":"S Bonassi","year":"2001","unstructured":"Bonassi S, Fenech M, Lando C et al (2001) HUman MicroNucleus project: international database comparison for results with the cytokinesis-block micronucleus assay in human lymphocytes: I. Effect of laboratory protocol, scoring criteria, and host factors on the frequency of micronuclei. Environ Mol Mutagen 37:31\u201345","journal-title":"Environ Mol Mutagen"},{"key":"1017_CR38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/mutage\/gel018","volume":"21","author":"B Patino-Garcia","year":"2006","unstructured":"Patino-Garcia B, Hoegel J, Varga D, Hoehne M, Michel I, Jainta S, Kreienberg R, Maier C, Vogel W (2006) Scoring variability of micronuclei in binucleated human lymphocytes in a case-control study. Mutagenesis 21:191\u2013197","journal-title":"Mutagenesis"},{"key":"1017_CR39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1383-5718(02)00248-6","volume":"534","author":"M Fenech","year":"2003","unstructured":"Fenech M, Bonassi S, Turner J et al (2003) Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project. Mutat Res 534:45\u201364","journal-title":"Mutat Res"},{"key":"1017_CR40","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.dnarep.2006.05.026","volume":"5","author":"S Burma","year":"2006","unstructured":"Burma S, Chen BP, Chen DJ (2006) Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 5:1042\u20131048","journal-title":"DNA Repair (Amst)"},{"key":"1017_CR41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1667\/RR0784.1","volume":"171","author":"M Frankenberg-Schwager","year":"2009","unstructured":"Frankenberg-Schwager M, Gebauer A, Koppe C, Wolf H, Pralle E, Frankenberg D (2009) Single-strand annealing, conservative homologous recombination, nonhomologous DNA end joining, and the cell cycle-dependent repair of DNA double-strand breaks induced by sparsely or densely ionizing radiation. Radiat Res 171:265\u2013273","journal-title":"Radiat Res"},{"key":"1017_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2008.07.028","volume":"90","author":"K Koch","year":"2009","unstructured":"Koch K, Wrona A, Dikomey E, Borgmann K (2009) Impact of homologous recombination on individual cellular radiosensitivity. Radiother Oncol 90:265\u2013272","journal-title":"Radiother Oncol"},{"key":"1017_CR43","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/sj.onc.1205200","volume":"21","author":"C Baldeyron","year":"2002","unstructured":"Baldeyron C, Jacquemin E, Smith J, Jacquemont C, De OI, Gad S, Feunteun J, Stoppa-Lyonnet D, Papadopoulo D (2002) A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene 21:1401\u20131410","journal-title":"Oncogene"},{"key":"1017_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2005.08.003","volume":"240","author":"DT Bau","year":"2006","unstructured":"Bau DT, Mau YC, Shen CY (2006) The role of BRCA1 in non-homologous end-joining. Cancer Lett 240:1\u20138","journal-title":"Cancer Lett"},{"key":"1017_CR45","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ijrobp.2009.10.020","volume":"76","author":"B Ernestos","year":"2010","unstructured":"Ernestos B, Nikolaos P, Koulis G, Eleni R, Konstantinos B, Alexandra G, Michael K (2010) Increased chromosomal radiosensitivity in women carrying BRCA1\/BRCA2 mutations assessed with the G2 assay. Int J Radiat Oncol Biol Phys 76:1199\u20131205","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1017_CR46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/djn440","volume":"101","author":"GA Berrington de","year":"2009","unstructured":"de Berrington GA, Berg CD, Visvanathan K, Robson M (2009) Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. J Natl Cancer Inst 101:205\u2013209","journal-title":"J Natl Cancer Inst"},{"key":"1017_CR47","doi-asserted-by":"crossref","first-page":"7025","DOI":"10.1158\/1078-0432.CCR-06-1244","volume":"12","author":"S Shanley","year":"2006","unstructured":"Shanley S, McReynolds K, Ardern-Jones A et al (2006) Late toxicity is not increased in BRCA1\/BRCA2 mutation carriers undergoing breast radiotherapy in the United Kingdom. Clin Cancer Res 12:7025\u20137032","journal-title":"Clin Cancer Res"},{"key":"1017_CR48","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1186\/bcr1668","volume":"9","author":"A Broeks","year":"2007","unstructured":"Broeks A, Braaf LM, Huseinovic A et al (2007) Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 9:R26","journal-title":"Breast Cancer Res"},{"key":"1017_CR49","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijrobp.2003.09.042","volume":"58","author":"J Shorrocks","year":"2004","unstructured":"Shorrocks J, Tobi SE, Latham H, Peacock JH, Eeles R, Eccles D, McMillan TJ (2004) Primary fibroblasts from BRCA1 heterozygotes display an abnormal G1\/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative stress or mitomycin C treatment. Int J Radiat Oncol Biol Phys 58:470\u2013478","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1017_CR50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/carcin\/bgi254","volume":"27","author":"YJ Lee","year":"2006","unstructured":"Lee YJ, Park SJ, Ciccone SL, Kim CR, Lee SH (2006) An in vivo analysis of MMC-induced DNA damage and its repair. Carcinogenesis 27:446\u2013453","journal-title":"Carcinogenesis"},{"key":"1017_CR51","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1158\/1078-0432.CCR-05-1048","volume":"11","author":"MS Heijden van der","year":"2005","unstructured":"van der Heijden MS, Brody JR, Dezentje DA et al (2005) In vivo therapeutic responses contingent on Fanconi anemia\/BRCA2 status of the tumor. Clin Cancer Res 11:7508\u20137515","journal-title":"Clin Cancer Res"},{"key":"1017_CR52","first-page":"305","volume":"9","author":"P Chalasani","year":"2008","unstructured":"Chalasani P, Kurtin S, Dragovich T (2008) Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutation. JOP 9:305\u2013308","journal-title":"JOP"},{"key":"1017_CR53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/carcin\/bgi226","volume":"27","author":"S Beetstra","year":"2006","unstructured":"Beetstra S, Salisbury C, Turner J, Altree M, McKinnon R, Suthers G, Fenech M (2006) Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiency. Carcinogenesis 27:517\u2013524","journal-title":"Carcinogenesis"},{"key":"1017_CR54","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1102574","volume":"306","author":"MJ Daniels","year":"2004","unstructured":"Daniels MJ, Wang Y, Lee M, Venkitaraman AR (2004) Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 306:876\u2013879","journal-title":"Science"},{"key":"1017_CR55","first-page":"191","volume":"31","author":"AB Jonsdottir","year":"2009","unstructured":"Jonsdottir AB, Vreeswijk MP, Wolterbeek R, Devilee P, Tanke HJ, Eyfjord JE, Szuhai K (2009) BRCA2 heterozygosity delays cytokinesis in primary human fibroblasts. Cell Oncol 31:191\u2013201","journal-title":"Cell Oncol"},{"key":"1017_CR56","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1242\/jcs.068015","volume":"123","author":"S Lekomtsev","year":"2010","unstructured":"Lekomtsev S, Guizetti J, Pozniakovsky A, Gerlich DW, Petronczki M (2010) Evidence that the tumor-suppressor protein BRCA2 does not regulate cytokinesis in human cells. J Cell Sci 123:1395\u20131400","journal-title":"J Cell Sci"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1017-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1017-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:32:35Z","timestamp":1559219555000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1017-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,13]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1017"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1017-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,13]]}}}